Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 4, 2022
- Accession no.
- 0001209191-22-016484
- Filed
- Mar 4, 2022
- Trade date
- Feb 18, 2020-Mar 4, 2022
- Filing delay
- 745 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market purchases total $28.6M. It was filed 745 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | Common Stock | CConversionAcquired | +2,118,214 | – | – | 2,118,214 | Indirect | |
| Feb 18, 2020 | Common Stock | PPurchaseAcquired | +400,000 | $17.00 | +$6,800,000 | 2,518,214 | Indirect | |
| Jul 13, 2020 | Common Stock | PPurchaseAcquired | +150,000 | $26.00 | +$3,900,000 | 2,668,214 | Indirect | |
| Feb 8, 2021 | Common Stock | PPurchaseAcquired | +300,000 | $45.00 | +$13,500,000 | 300,000 | Indirect | |
| Mar 2, 2022 | Common Stock | PPurchaseAcquired | +116,290 | $18.94 | +$2,202,532.6 | 116,290 | Indirect | |
| Mar 3, 2022 | Common Stock | PPurchaseAcquired | +54,764 | $18.42 | +$1,008,752.88 | 171,054 | Indirect | |
| Mar 3, 2022 | Common Stock | PPurchaseAcquired | +10,873 | $19.13 | +$208,000.49 | 181,927 | Indirect | |
| Mar 4, 2022 | Common Stock | PPurchaseAcquired | +56,300 | $17.69 | +$995,947 | 238,227 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | Common Stock | CConversionDisposed | −1,569,539 | – | – | 0 | Indirect | |
| Feb 18, 2020 | Common Stock | CConversionDisposed | −548,675 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.